These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 194349)
41. [Study of the effect of migration to high-mountain regions on the blood lipoprotein system]. Aĭtbaev KA; Madaminov IaK; Meĭmanaliev TS; Shleĭfer EA; Kim NM Kosm Biol Aviakosm Med; 1990; 24(6):45-6. PubMed ID: 2149868 [TBL] [Abstract][Full Text] [Related]
42. Low-density and high-density lipoprotein subspecies and risk for premature coronary artery disease. Brunzell JD; Hokanson JE Am J Med; 1999 Aug; 107(2A):16S-18S. PubMed ID: 10484232 [No Abstract] [Full Text] [Related]
43. [Significance of serum beta-lipoprotein subfraction determination (author's transl)]. Yang CG Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Sep; 9(3):219-22. PubMed ID: 7338180 [No Abstract] [Full Text] [Related]
45. Progression and regression of atherosclerotic lesions. Wissler RW Adv Exp Med Biol; 1978; 104():77-109. PubMed ID: 213957 [No Abstract] [Full Text] [Related]
46. [Effect of low-density lipoproteins on neutrophil chemotaxis in chronic ischemic heart disease patients]. Beĭko VA Kardiologiia; 1985 May; 25(5):101-3. PubMed ID: 4021286 [No Abstract] [Full Text] [Related]
47. [Dynamics of free and protein-bound blood oxyproline in acute surgical diseases of the abdominal organs]. Karaman NV; Krylovskiĭ SI Klin Khir (1962); 1981 Apr; (4):15-7. PubMed ID: 7241898 [No Abstract] [Full Text] [Related]
48. [Diagnostic value of the determination of free oxyproline in hereditary and acquired collagenoses]. Askerova TA; Iusifova NA; Gasanova GT; Kerimova AR Klin Lab Diagn; 2009 Sep; (9):15-7. PubMed ID: 19882864 [TBL] [Abstract][Full Text] [Related]
49. [Methods of studying oxyproline in blood and urine]. Osadchuk MA Lab Delo; 1979; (8):456-8. PubMed ID: 89250 [No Abstract] [Full Text] [Related]
50. Plasma lipoproteins and coronary heart disease. Scanu AM Ann Clin Lab Sci; 1978; 8(2):79-83. PubMed ID: 205164 [TBL] [Abstract][Full Text] [Related]
51. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia]. Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185 [No Abstract] [Full Text] [Related]
52. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease. Haviar V; Riecanský L; Kusá O; Luknárová O Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417 [No Abstract] [Full Text] [Related]
53. [Hydroxyproline content in blood and urine in ischemic heart disease]. Nikitin IuP; Korobkova EN Kardiologiia; 1977 Aug; 17(8):84-9. PubMed ID: 200786 [TBL] [Abstract][Full Text] [Related]
54. Management of hyperlipidemia in coronary artery disease. Kossmann CE J Tenn Med Assoc; 1982 Aug; 75(8):543-7. PubMed ID: 7132342 [No Abstract] [Full Text] [Related]
55. [Elastolytic activity and free oxyproline in the blood in different types of hyperlipoprotenemia in patients with ischemic heart disease]. Mikunis RI; Serkova VK Ter Arkh; 1977; 49(4):37-40. PubMed ID: 194349 [No Abstract] [Full Text] [Related]